FDA accepts Aquestive Therapeutics’ Anaphylm NDA resubmission
The FDA set a PDUFA goal date of March 16, 2027.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.